|
|
| Phases of Development | Preclinical | Phase I | Phase I/II | Phase II | Phase II/III | Phase III | Registration | Approved | Marketed |
|---|
| Cancer | 11 | 16 | 0 | 8 | 1 | 6 | 2 | 1 | 3 | | Diagnostic | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 2 | | Renal | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)